Immage Biotherapeutics

(OTC) IMMG

Current Price$0.00

Market Cap$200

Since IPO (2015)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Immage Biotherapeutics Financials at a Glance

Market Cap

$200

Revenue (TTM)

$0.00

Net Income (TTM)

$114.57K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.84 (High)

Dividend

$0.00

Beta (Volatility)

14.84 (High)

Price

$0.00

Volume

500

Open

$0.00

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

14.84 (High)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

IMMG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immage Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

Bethesda, US

IMMG Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-1%

Return on Assets

-89%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

151.75M

Volume

500

Avg. Volume

7.937

Financials (TTM)

Gross Profit

$8.53K

Operating Income

$216.48K

EBITDA

$207.95K

Operating Cash Flow

$215.82K

Capital Expenditure

$0.00

Free Cash Flow

$215.82K

Cash & ST Invst.

$196.72K

Total Debt

$52.77K

Immage Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2017YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$66.67

N/A

Employees

N/A

Net Income

$44.09

+99.9%

EBITDA

$41.96K

+37.6%

Quarterly Fundamentals

Name

Q1 2017YOY CHG

Net Cash

$53.69K

-83.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-89.05%

N/A

Return on Invested Capital

-1.16%

N/A

Free Cash Flow

$71.95K

-21.5%

Operating Cash Flow

$71.95K

-21.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CHFIChina Finance, Inc.

CHFIChina Finance, Inc.$0.00+0.00%

BLPFFBLOK Technologies Inc.

BLPFFBLOK Technologies Inc.$0.00+0.00%

CIVXCTR Investments & Consulting, Inc.

CIVXCTR Investments & Consulting, Inc.$0.00+0.00%

XYNHXynergy Holdings, Inc.

XYNHXynergy Holdings, Inc.$0.00+0.00%

AXTGAxis Technologies Group, Inc.

AXTGAxis Technologies Group, Inc.$0.00+0.00%

RNBIRainbow International Corp.

RNBIRainbow International Corp.$0.00+0.00%

BITCFFirst Bitcoin Capital Corp.

BITCFFirst Bitcoin Capital Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.10-0.02%

INTCIntel

INTCIntel$96.48-0.03%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.02+2.47%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+1.07%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.75+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.83+0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.12-0.09%

Questions About IMMG

What is the current price of Immage Biotherapeutics?

Immage Biotherapeutics is trading at N/A per share.

What is the 52-week range for Immage Biotherapeutics?

Over the past 52 weeks, Immage Biotherapeutics has traded between N/A and N/A.

How much debt does Immage Biotherapeutics have?

Immage Biotherapeutics total debt is unavailable.

How much cash does Immage Biotherapeutics have on hand?

Immage Biotherapeutics does not have cash on hand data available.

What is Immage Biotherapeutics’s dividend yield?

Immage Biotherapeutics does not currently have a dividend yield.

Immage Biotherapeutics

Immage Biotherapeutics Financials at a Glance

IMMG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immage Biotherapeutics

IMMG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immage Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMMG

What is the current price of Immage Biotherapeutics?

What is the 52-week range for Immage Biotherapeutics?

How much debt does Immage Biotherapeutics have?

How much cash does Immage Biotherapeutics have on hand?

What is Immage Biotherapeutics’s dividend yield?

Premium Investing Services